DIANE TURNER: Open Payments
NPI 1205484565 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 30 payments from 10 companies in 2025. Trend: 2023 $974 · 2024 $1,349 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $175 |
| ABBVIE INC. | 11 | $140 |
| Novo Nordisk Inc | 4 | $77 |
| Lilly USA, LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: AIRSUPRA, QULIPTA, MOUNJARO, Symbravo, VRAYLAR, Ozempic, FARXIGA, Wegovy.
Industry payments across TX — which companies pay providers there.
